COMPANY PROFILE
"Experience you can trust"
Strategic Quote
“Dipharma is proud to have been reliably serving the life sciences industry for decades and will continue to do so for many years to come.”
Summary
Dipharma is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering about 40 APIs with DMFs registered worldwide.
Thanks to a workforce of about 600 skilled and highly committed employees, supported by four state-of-the-art CGMP facilities, located in the U.S.A. and Italy, Dipharma is strategically positioned to meet the dynamic needs of the pharmaceutical industry. Our fully Research and Development Centers drive innovation by developing cutting-edge chemical processes and crystalline forms tailored to meet the unique requirements of our customers.
Since 1970, Dipharma has managed to achieve a positive unbroken record of inspections by the major Regulatory Agencies and the CGMP manufacturing sites are equipped to supply quantities from laboratory to industrial scale, covering the entire lifecycle of a pharmaceutical substance. Dipharma has the right size and variety of scale-up capabilities to act as a global player and manage processes efficiently while offering flexibility and agility to promptly solve any challenge.
Experience you can trust.
Dipharma puts its heart and soul into supporting customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies.
- High-pressure hydrogenation*
- Nitration*
- Nitroesterification*
- Azide chemistry
- Borane reductions
- Carbohydrate chemistry
- Cross-coupling reactions
- Curtius reaction
- Dissolving metal reduction
- Enantioselective reactions
- Enzymatic chemistry
- Epichlorohydrin chemistry
- Hoffman reaction
- Hydrogen peroxide oxidations
- Use of nitroalkanes (Henry reaction)
- Wolff-Kishner reduction *Strategic cooperation with Biazzi SA, engineering sister company specializing in hazardous chemistry
Sustainability and Commitment
Dipharma is committed to 'making a positive difference'. For us, this means taking care of our employees, the community, all stakeholders, and the environment as much as we do for the products ultimately used to treat patients. This commitment encompasses the safety of consumers, our workers, our neighbours, and the sustainability of our operations for present and future generations. To achieve this, we implement continuous improvement programs daily to integrate the principles of Corporate Social Responsibility into our business and all corporate activities.
In 2024, in recognition of our continued commitment to improving sustainability, the international rating agency EcoVadis has awarded us the Bronze Medal. EcoVadis has rated Dipharma Francis's performance among the top 35% of all organizations surveyed, and the award is based on 21 indicators divided into four categories: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
Dipharma is actively working on a sustained path in defining its ESG strategy and reporting ambitions in compliance with the EU Corporate Sustainability Reporting Directive.
Our Products and Services
Exclusive Synthesis
What we offer
Dipharma provides a tailor-made development of innovative and proprietary chemical processes for new and complex molecules. Since the customers’ peace of mind is our concern, we guarantee a true turnkey CDMO service, with all the assistance and flexibility required through the different project stages.
We believe this unique platform will expedite the journey to success of our international clients. Our know-how in action
Our human and technological resources work together on chemical processes for new and complex molecules. State-of-the-art kilolab, pilot and industrial facilities are our assets to cover clinical and commercial supply with the highest standards.
Catalogue APIs
What we offer
Dipharma develops proprietary chemical processes and alternative solutions to support the generic API industry. Our customers can rely on a true turnkey service where commercially competitive products are promptly conceived and manufactured in full compliance with third-party intellectual property rights. Along with quality, confidentiality, safety and the ability to meet deadlines, we ensure a well-established and reliable supply chain for our clients’ peace of mind.
Our current product portfolio comprises over 40 high quality APIs. To know more about aur generic products, please visit our website.
